A Phase 1 Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ZSP1273 and the Effect of Food on ZSP1273 Pharmacokinetics in Chinese Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2019
Price : $35 *
At a glance
- Drugs ZSP-1273 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Guangdong Zhongsheng Pharmaceutical
- 12 Aug 2019 Status changed from recruiting to completed.
- 05 Nov 2018 Status changed from not yet recruiting to recruiting.
- 27 Sep 2018 New trial record